Chronic pancreatitis: The perspective of pain generation by neuroimmune interaction

Gut

Volumn 52, Issue 6, 2003, Pages 907-911

  Di Sebastiano, P ^a   Di Mola, F F ^a   Bockman, D E ^a   Friess, H ^a   Buchler M W ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; NERVE GROWTH FACTOR; NEUROPEPTIDE; SUBSTANCE P; TACHYKININ RECEPTOR;

CHRONIC PAIN; CHRONIC PANCREATITIS; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOPATHOLOGY; INFLAMMATION; INFLAMMATORY CELL; NERVE GROWTH; NEUROIMMUNOLOGY; NEUROPATHOLOGY; PEPTIDERGIC NERVOUS SYSTEM; PRIORITY JOURNAL; REVIEW; SPLANCHNIC NERVE;

CHRONIC DISEASE; HUMANS; NEUROIMMUNOMODULATION; NEUROPEPTIDES; PAIN; PANCREAS; PANCREATITIS;

EID: 0037508816     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.52.6.907     Document Type: Review

References (49)

1. Steer ML, Waxman I, Freedman S. Chronic pancreatitis. N Engl J Med 1995;332:1482-90.
2. Büchler MW, Friess H, Uhl W, et al. Chronic pancreatitis: Novel Concepts in Biology and Therapy. Oxford: Blackwell Publishing, 2002.
3. Beger HG, Büchler M, Malfertheiner P. Standards in Pancreatic Surgery. New York: Springer-Verlag, 1993.
4. Warshaw AL, Banks PA, Fernandez-Del, et al. AGA Technical review: treatment of pain in chronic pancreatitis. Gastroenterology 1998;115:765-76.
5. Beger HG, Krautzberger W, Bittner R, et al. Duodenum-preserving resection of the head of the pancreas in patients with severe chronic pancreatitis. Surgery 1985;97:467-73.
6. Glasbrenner B, Adler G. Evaluating pain and the quality of life in chronic pancreatitis. Int J Pancreatol 1997;22:163-70.
7. Reber HA, Karanjia ND, Alvarez C, et al. Pancreatic blood flow in cats with chronic pancreatitis. Gastroenterology 1992;103:652-9.
8. Karanjia ND, Singh SM, Widdison AL, et al. Pancreatic ductal and interstitial pressure in cats with chronic pancreatitis. Dig Dis Sci 1992;37:268-73.
9. Amman RW, Muellhaupt B, Zürich Pancreatitis Study Group. The natural history of pain in alcoholic chronic pancreatitis. Gastroenterology 1999;116:1132-40.
10. Jensen AR, Matzen P, Malchow-Moller A, et al. Pattern of pain, duct morphology and pancreatic function in chronic pancreatitis: a comparative study. Scand J Gastroenterol 1984;19:334-8.
11. Malfertheiner P, Büchler M, Stanescu A, et al. Pancreatic morphology and function in relationship to pain in chronic pancreatitis. Int J Pancreatol 1987;2:59-66.
12. Lankisch PG, Lohr-Happe A, Otto J, et al. Natural course of chronic pancreatitis. Pain, exocrine and endocrine pancreatic insufficiency and prognosis of the disease. Digestion 1993;54:148-55.
13. Levy P, Lesur G, Belghiti J, et al. Symptomatic duodenal stenosis in chronic pancreatitis: a study of 17 cases in a medical surgical series of 306 patients. Pancreas 1993;8:563-7.
14. Becker V, Mischke U. Groove pancreatitis. Int J Pancreatol 1991;10:173-82.
15. Prinz RA, Aranha GV, Greenlee HB, et al. Common duct obstruction in patients with intractable pain of chronic pancreatitis. Am Surg 1982;48:373-7.
16. Manes G, Pieramico O, Uomo G. Pain in chronic pancreatitis: recent pathogenetic findings. Minerva Gastroenterol Dietol 1992;38:137-43.
17. Bradley EL 3rd. Pancreatic duct pressure in chronic pancreatitis. Am J Surg 1982;144:313-16.
18. Ebbehoj N. Pancreatic tissue fluid pressure and pain in chronic pancreatitis. Dan Med Bull 1992;39:128-33.
19. Ebbehoj N, Borly L, Bulow J, et al. Pancreatic tissue fluid pressure in chronic pancreatitis. Relation to pain, morphology, and function. Scand J Gastroenterol 1990;25:1046-51.
20. Ebbehoj N, Borly L, Madsen P, et al. Pancreatic tissue fluid pressure during drainage operations for chronic pancreatitis. Scand J Gastroenterol 1990;25:1041-5.
21. Manes G, Buchler M, Pieramico O, et al. Is increased pancreatic pressure related to pain in chronic pancreatitis? Int J Pancreatol 1994;15:113-17.
22. Beger HG, Schlosser W, Friess HM, et al. Duodenum-preserving head resection in chronic pancreatitis changes the natural course of the disease: a single-center 26-year experience. Ann Surg 1999;230:512-19.
23. Ihse I, Borch K, Larsson J. Chronic pancreatitis: results of operations for relief of pain. World J Surg 1990;14:53-8.
24. Uhl W, Anghelacopoulos SE, Friess H, et al. The role of octreotide and somatostatin in acute and chronic pancreatitis. Digestion 1999;60(suppl 2):23-31.
25. Malfertheiner P, Mayer D, Buchler M, et al. Treatment of pain in chronic pancreatitis by inhibition of pancreatic secretion with octreotide. Gut. 1995;36:450-4.
26. Di Magno EP. Toward understanding (and management) of painful chronic pancreatitis. Gastroenterology 1999;116:1252-7.
27. Karanjia ND, Widdison AL, Leung F, et al. Compartment syndrome in experimental chronic obstructive pancreatitis: effect of decompressing the main pancreatic dust. Br J Surg 1994;81:259-64.
28. di Mola FF, Friess H, Martignoni ME, et al. Connective tissue growth factor is a regulator for fibrosis in human chronic pancreatitis. Ann Surg 1999;230:63-71.
29. Di Sebastiano P, Fink T, Weihe E, et al. Immune cell infiltration and growth- associated protein 43 expression correlate with pain in chronic pancreatitis. Gastroenterology 1997;112:1648-55.
30. Gullo L, Barbara L. Treatment of pancreatic pseudocysts with octreotide. Lancet 1991;338:540-41.
31. Toma H, Winston J, Micci MA, et al. Nerve growth factor expression is up-regulated in the rat model of L-arginine-induced acute pancreatitis. Gastroenterology 2000;119:1373-81.
32. Friess H, Zhu ZW, di Mola FF, et al. Nerve growth factor and its high affinity receptor in chronic pancreatitis. Ann Surg 1999;230:615-24.
33. Keith RG, Keshavjee SH, Kerenyi NR. Neuropathology of chronic pancreatitis in humans. Can J Surg 1985;28:207-11.
34. Bockman DE, Buchler M, Malfertheiner P, et al. Analysis of nerves in chronic pancreatitis. Gastroenterology 1988;94:1459-69.
35. Buchler M, Weihe E, Friess H, et al. Changes in peptidergic innervation in chronic pancreatitis. Pancreas 1992;7:183-92.
36. Fink T, Di Sebastiano P, Büchler M, et al. Growth associated protein-43 and protein gene product 9.5 innervation in human pancreas: changes in chronic pancreatitis. Neuroscience 1994;63:249-66.
37. Zhu ZW, Friess H, Wang L, et al. Brain-derived neurotrophic factor (BDNF) is upregulated and associated with pain in chronic pancreatitis. Dig Dis Sci 2001;46:1633-9.
38. Di Sebastiano P, Weihe E, di Mola FF, et al. Neuroimmune appendicitis. Lancet 1999;354:461-6.
39. Weihe E, Nohr D, Muller S, et al. The tachykinin neuroimmune connection in inflammatory pain. Ann N Y Acad Sci 1991;632:283-95.
40. Shrikande S, Friess H, di Mola FF, et al. NK-1 receptor gene expression is related to pain in chronic pancreatitis. Pain 2001;91:209-17.
41. Di Sebastiano P, di Mola FF, Di Febbo C, et al. Expression of interleukin-8 (IL-8) and substance P in human chronic pancreatitis. Gut 2000;47:423-8.
42. Mantyh CR, Gates TS, Zimmerman RP, et al. Receptor binding sites for substance P, but not substance K or neuromedin K, are expressed in high concentration by arterioles, venules, and lymph nodules in surgical specimen obtained from patients with ulcerative colitis and Crohn's disease. Proc Natl Acad Sci U S A 1988;85:3235-9.
43. Mantyh PW, Catton MD, Boehmer CG, et al. Receptor for sensory neuropeptides in human inflammatory diseases: implications for the effector role of sensory neurons. Peptides 1989;10:627-45.
44. Mantyh PW, Mantyh CR, Gates T, et al. Receptor binding sites for substance P and substance K in the canine gastrointestinal tract and their possible role in inflammatory bowel disease. Neuroscience 1988;25:817-37.
45. Di Sebastiano P, Grossi L, di Mola FF, et al. SR 140333, a substance P receptor antagonist, influences morphological and motor changes in rat experimental colitis. Dig Dis Sci 1999;44:439-44.
46. Stanisz AM, Stanisz JA. Nerve growth factor and neuroimmune interactions in inflammatory diseases. Ann N Y Acad Sci 2000;917:268-72.
47. Levi-Montalcini R, Skaper SD, Dal Toso R, et al. Nerve growth factor: from neurotrophin to neurokine. Trends Neurosci 1996;19:514-20.
48. Jafarian-Tehrani M, Sternberg EM. Animal models of neuroimmune interactions in inflammatory diseases. J Neuroimmunol 1999;100:13-20.
49. Di Sebastiano P, di Mola FF, Artese L, et al. Beneficial effects of BB-94, a matrix metalloproteinase inhibitor, in rat experimental colitis. Digestion 2001;63:234-9.